Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$20,043,377
+$6,913,724 QoQ
Shares Held
79,651
+31.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#610
of 4,168 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Madison Asset Management, LLC holds $138,988,503 across 8 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
55,520 | $66,592,359 | |
| 2 | JNJ |
Johnson & Johnson
|
136,792 | $34,741,064 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
79,651 | $20,043,377 | |
| 4 | PFE |
Pfizer Inc
|
242,132 | $5,830,538 | |
| 5 | AMGN |
Amgen Inc
|
11,539 | $4,178,502 | |
| 6 | AZN |
Astrazeneca PLC
|
21,310 | $4,040,802 | |
| 7 | MRK |
Merck & Co., Inc.
|
23,786 | $3,056,501 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,000 | $505,360 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,043,377 | 79,651 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $13,129,653 | 60,369 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $14,948,044 | 65,421 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $15,606,027 | 67,401 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,029,039 | 70,192 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $16,608,650 | 79,270 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $14,967,137 | 84,227 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $17,922,692 | 90,757 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $16,072,796 | 93,708 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,993,817 | 21,932 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,358,178 | 15,217 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,355,998 | 9,097 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $469,638 | 2,906 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $413,635 | 3,082 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $483,832 | 3,159 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $554,091 | 3,418 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $498,678 | 3,683 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,151,080 | 10,671 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,107,701 | 9,834 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $985,667 | 9,108 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,029,175 | 9,605 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $841,301 | 9,605 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $943,018 | 9,605 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $308,569 | 4,050 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||